After COVID-19, what’s next for EU medicines policies?

Continuing our successful online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.

A one-on-one interview with Professor Guido Rasi, former Executive Director of the European Medicines Agency (EMA).

Professor Rasi will talk about his time at the helm of Europe’s top regulator; the power balance between pharma and governments; the impact of the pandemic on the pharmaceutical regulatory framework and the innovation landscape and trends in Europe and beyond.